期刊文献+

糖皮质激素α受体在各期血管瘤组织中的表达 被引量:3

Expression of Glucocorticoid Receptor α in Different Stages of Heman gioma
暂未订购
导出
摘要 目的通过测定各期血管瘤组织中糖皮质激素α受体(GRα)的表达,研究其与各期血管瘤的关系及临床意义。方法采用免疫组织化学方法检测经病理证实的33例增殖期、19例退化期和13例退化完成期标本组织中GRα表达情况,以8例正常皮肤组织标本作为对照组。结果GRα在血管瘤各期标本组织及正常皮肤组织中的表达阳性灰度值分别为131.26±8.07,123.79±8.87,118.83±9.71,109.61±9.95,各期血管瘤与正常对照组差别均有统计学意义(P均<0.05),增殖期与退化期以及退化完成期的差别也有统计学意义(P<0.01),且随血管瘤退化GRα表达减少。结论各期血管瘤组织中均有不同程度GRα表达,GRα表达与血管瘤分期密切相关。 Objective To examine the expression of glucocorticoid receptor α(GRα) in each stage of hemangioma, Methods Sections of 33 proliferative hemangionms, 19 involuting henrangiomas, 13 involuted hemangiomas and 8 controls were inmmunostained for GRα, Results The GRα-positive gray scale in each stage of hemangiomas ,and controls were 131.26±8.07,123.79± 8.87,118.83±9.71,109.61± 9. 95, respectively. There was difference between each stage of hemangiomas and controls( P〈 0.05 )and there was also significant difference between proliferative and involuting, involuted stages(P〈0. 01 ), The expression of GRα reduced with the degeneration of henmangiomas. Conclusion Each stage of henangioma has the expression of GRα and it is closely related to the stagings of hemangioma.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2005年第9期931-932,共2页 Journal of Applied Clinical Pediatrics
关键词 血管瘤 免疫组织化学 糖皮质激素受体 hemangioma immunohistochemistry glucocorticoid receptor
  • 相关文献

参考文献10

二级参考文献27

  • 1王赞尧,王勇.糖皮质激素瘤内注射治疗婴幼儿血管瘤[J].中华小儿外科杂志,1993,14(3):133-135. 被引量:11
  • 2White CW, Sondheimer HM, Crouch EC, et al. Treatment of pulmonary hemangionatosis with recombinant interferon alfa- 2a[J]. N Engl J Med, 1989,320(18): 1197 - 1200.
  • 3Ezekowitz RAB, Mulliken J, Folkman J, et al. Interferon alpha - 2a therapy for life- threatening hemangiomas of infancy[J ]. N Engl J Med, 1992,326(22): 1456 - 1463.
  • 4Marler JJ, Rubin JB, Trede NS, et al. Successful anttiangiogenic therapy of giant cell angioblastoma with interferon alfa 2b: report of 2cases[J]. Pediatrics,2002,109(2) :37 - 41.
  • 5Barlow CF,Priebe C,Mulliken JB, et al. Spastic diplegia as a complication of interferon alfa - 2a treatment of hemangiomas of infancy [J]. J Pediatr, 1998,132: 527 - 530.
  • 6Walter JW, North PE, Waner M, et al. Somatic mutation of vascular endothelial growth factor recepters in juvenile hemangioma[J]. Genes Chromosomes & Cancer,2002,33: 295- 303.
  • 7North PE,Waner M,Brodsky MC, et al. Are infantile hemangiomas of placental origin[J]? Ophthalmology, 2002,109(4): 633 - 634.
  • 8仉红刚.细胞凋亡DNA检测技术概况[J].国外医学(临床生物化学与检验学分册),1997,18(1):12-14. 被引量:7
  • 9Leung DY,Hamid QA, Vottero A,et al.Association of glucocorticoid insensitive with increased expression of glucocorticoid receptor β[J].J Exp Med,1997,186(3):1567-1573.
  • 10Okaley RH, Jewell CM, Yudt MR, et al. The dominant negative activity of the human glucocorticoid receptor β isoform[J]. J Biol Chem,1999,274(39):27857-27866.

共引文献55

同被引文献23

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部